Moffitt study find loss of certain protein is associated with poor prognosis in breast, lung cancer

Moffitt Cancer Center researchers have found that breast and lung cancer patients who have low levels of a protein called tristetraprolin have more aggressive tumors and a poorer prognosis than those with high levels of the protein. Their study was published in the Dec. 26 issue of PLoS One. —> Read More Here


Leave a Reply

Your email address will not be published. Required fields are marked *